- Home
- CRVS vs SSYS Comparison
CRVS vs SSYS Comparison
Compare CRVS & SSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- SSYS
- Stock Information
- Founded
- CRVS 2014
- SSYS 1989
- Country
- CRVS United States
- SSYS United States
- Employees
- CRVS N/A
- SSYS N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- SSYS Computer peripheral equipment
- Sector
- CRVS Health Care
- SSYS Technology
- Exchange
- CRVS Nasdaq
- SSYS Nasdaq
- Market Cap
- CRVS 451.0M
- SSYS 534.6M
- IPO Year
- CRVS 2016
- SSYS 1994
- Fundamental
- Price
- CRVS $8.94
- SSYS $9.39
- Analyst Decision
- CRVS Buy
- SSYS Strong Buy
- Analyst Count
- CRVS 4
- SSYS 4
- Target Price
- CRVS $12.83
- SSYS $11.50
- AVG Volume (30 Days)
- CRVS 1.0M
- SSYS 804.8K
- Earning Date
- CRVS 11-12-2024
- SSYS 11-13-2024
- Dividend Yield
- CRVS N/A
- SSYS N/A
- EPS Growth
- CRVS N/A
- SSYS N/A
- EPS
- CRVS N/A
- SSYS N/A
- Revenue
- CRVS N/A
- SSYS $578,436,000.00
- Revenue This Year
- CRVS N/A
- SSYS N/A
- Revenue Next Year
- CRVS N/A
- SSYS $4.53
- P/E Ratio
- CRVS N/A
- SSYS N/A
- Revenue Growth
- CRVS N/A
- SSYS N/A
- 52 Week Low
- CRVS $1.30
- SSYS $6.05
- 52 Week High
- CRVS $10.00
- SSYS $14.93
- Technical
- Relative Strength Index (RSI)
- CRVS 60.34
- SSYS 62.71
- Support Level
- CRVS $8.02
- SSYS $8.80
- Resistance Level
- CRVS $8.71
- SSYS $10.60
- Average True Range (ATR)
- CRVS 0.86
- SSYS 0.53
- MACD
- CRVS -0.17
- SSYS 0.12
- Stochastic Oscillator
- CRVS 52.25
- SSYS 65.13
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers, and autoimmune diseases. The company's primary product candidate is Soquelitinib (CPI-818), an oral, small-molecule drug that selectively inhibits ITK (interleukin-2-inducible T cell kinase). The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About SSYS Stratasys Ltd. (Israel)
Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.